Potent Induction of Apoptosis by β-Lapachone in Human Multiple Myeloma Cell Lines and Patient Cells

Molecular Medicine

Volumn 6, Issue 12, 2000, Pages 1008-1015

  Li, Youzhi ^a   Li, Chiang J ^a   Yu, Donghui ^a   Pardee, Arthur B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti survival Effects; Human MM; PARP Cleavage; Poly (ADP ribose) Polymerase (PARP); Rauscher Leukemia Virus

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BETA LAPACHONE; BETA-LAPACHONE; CYTOCHROME C; DNA FRAGMENT; NAPHTHOQUINONE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; DOSE RESPONSE; HUMAN; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; RECURRENT DISEASE; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL SURVIVAL; CYTOCHROME C GROUP; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MULTIPLE MYELOMA; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECURRENCE; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0034570848     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402052     Document Type: Article

References (25)

1. S.P. Treon G. Teoh M. Urashima A. Ogata D. Chauhan J. Webb K. Anderson Antiestrogens induce apoptosis of multiple myeloma cells Blood 1998 92 1749 1757 9716605 1:CAS:528:DyaK1cXls1Shs7s%3D
2. Anderson K, Kyle RA, Berenson JR, Dalton WS.(1999) Recent Advances in the Biology and Treatment of Multiple Myeloma. Annual Meeting Report 1999.
3. S.C. Hooker Lomatiol. Part II. Its occurence, constitution, relation to and conversion into lapachol. Also a synthesis of lapachol J. Am. Chem. Soc. 1936 58 1181 1190 10.1021/ja01298a032 1:CAS:528:DyaA28XksFWntg%3D%3D
4. O. de Goncalves Lima I.L. D’Albuquerque C. de Goncalves Lima M.H. Dalla Maia Substancias antimicrobianas de plantas superiores Rev. Inst. Antibiot. Univ. Recife. 1962 4 3 17
5. C.J. Li L. Averboukh A.B. Pardee Betalapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin J. Biol. Chem. 1993 268 22463 22468 1:CAS:528:DyaK3sXlslelt7k%3D 8226754
6. A.M. Goncalves M.E. Vasconcellos R. Docampo N.S. Cruz W.R. Souza W. Leon Evaluation of the toxicity of 3-allyl-β-lapachone against trypanosoma cruzi bloodstream forms Mol. Biochem. Parasitology. 1980 1 167 176 10.1016/0166-6851(80)90015-8 1:CAS:528:DyaL3cXltVOqsbo%3D
7. K. Schaffner-Sabba K.H. Schmidt-Ruppin W. Wehrli A.R. Schuerch J.W.F. Wasley β-Lapachone: synthesis of derivatives and activities in tumor models J. Med. Chem. 1984 27 990 994 10.1021/jm00374a010 1:CAS:528:DyaL2cXksFCkt7s%3D 6205152
8. C.J. Li L.J. Zhang B.J. Dezube C.S. Crumpacker A.B. Pardee Three inhibitors of type I human immunodeficiency virus long terminal repeat-directed gene expression and virus replication Proc. Natl. Acad. Sci. USA. 1993 90 1839 1842 10.1073/pnas.90.5.1839 1:CAS:528:DyaK3sXhs1Slsb4%3D 8446597
9. A.R. Schuerch W. Wehrli β-Lapachone, an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-α Eur. J. Biochem. 1978 84 197 205 10.1111/j.1432-1033.1978.tb12157.x 1:CAS:528:DyaE1cXhs1Gqsb0%3D 77223
10. R.J. Boorstein A.B. Pardee β-Lapachone greatly enhances MMS lethality to human fibroblasts Biochem. Biophys. Res. Commun. 1984 118 828 834 10.1016/0006-291X(84)91469-4 1:CAS:528:DyaL2cXhtlektLw%3D 6704108
11. D.A. Boothman D.K. Trask A.B. Pardee Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I Cancer Res. 1989 49 605 612 1:CAS:528:DyaL1MXovVWltQ%3D%3D 2535961
12. C.J. Li L. Averboukh A.B. Pardee β-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin J. Biol. Chem. 1993 268 22463 22468 1:CAS:528:DyaK3sXlslelt7k%3D 8226754
13. Y.Z. Li C.J. Li A.V. Pinto A.B. Pardee Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by β-lapachone in human carcinoma cells Molec. Med. 1999 5 232 239 10.1007/BF03402120
14. Y. Tu F.H. Xu J. Liu R. Vescio J. Berenson C. Fady A. Lichtenstein Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide Blood 1996 88 1805 1812 8781438 1:CAS:528:DyaK28Xlt1Kku70%3D
15. A. Bloem H. Lockhorst Bcl-2 antisense therapy in multiple myeloma Pathol. Biol. (Paris) 1999 47 216 220 1:CAS:528:DyaK1MXisVagsb4%3D
16. K. Anderson Advances in the biology of multiple myeloma: therapeutic applications Sem. Oncol. 1999 26 suppl13 10 22 1:CAS:528:DyaK1MXntFOktLs%3D
17. T. Mosmann Rapid colorimertic assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Meth. 1983 65 55 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D
18. K. Anderson Introduction Sem. Oncol. 1999 26 1
19. C.J. Li D.J. Friedman C. Wang V. Metelev A.B. Pardee Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein Science 1995 268 429 431 10.1126/science.7716549 1:CAS:528:DyaK2MXltFKktbo%3D 7716549
20. C.J. Li Y.Z. Li A.V. Pinto A. Pardee Potent inhibition of tumor survival in vivo by β-lapachone plus taxol: combining drugs imposes different artificial checkpoints Proc. Natl. Acad. Sci. USA 1999 96 13369 13374 10.1073/pnas.96.23.13369 1:CAS:528:DyaK1MXns1GmtLg%3D 10557327
21. G. Zhang V. Gurtu S.R. Kain G. Yan Early detection of apoptosis using a fluorescent conjugate of annexin V BioTechniques 1997 23 525 531 10.2144/97233pf01 1:CAS:528:DyaK2sXmtVSnt70%3D 9298227
22. C.J. Li C. Wang A.B. Pardee Induction of apoptosis by β-lapachone in human prostate cancer cells Cancer Res. 1995 55 3712 3715 1:CAS:528:DyaK2MXnvVelsL4%3D 7641181
23. S. Rita R. Michele O. Patrizia B. Alessandra B. Sara G. Enrico Inhibition of protein kinase C in PHA-activated PBMC treated with anti-HLA class I monoclonal antibody is associated to decreased proliferation and expression of cell cycle related genes Biochem. Mol. Biol. Int. 1994 32 105 114 8012275 1:CAS:528:DyaK2cXisVajur4%3D
24. D.C. Case Jr D.J. Lee III B.D. Clarkson Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol Am. J. Med. 1977 63 897 903 10.1016/0002-9343(77)90543-5 605911
25. T. Otsuki O. Yamada J. Kurebayashi et al. Estrogen receptors in human myeloma cells Cancer Res. 2000 60 1434 1441 10728710 1:CAS:528:DC%2BD3cXhvFWrtLc%3D